Xeomin, Radiesse, and Belotero Facial/Neck Rejuvenational

Completed · Phase 4

Conditions studied: Photoaging

In brief

The purpose of this study is to determine the improvement in signs of photoaging and subject satisfaction after combination, global facial and/or neck treatment with IncobotulinumA (Xeomin), HA (Belotero) and/or calcium hydroxyapatite (Radiesse+, Radiesse Classic). All products will be used on-label FDA-cleared indications.

Key facts

Study ID

NCT05039723

Run by

Main Line Center for Laser Surgery

People needed

22

Starts

2021-09-01

Expected to finish

2022-07-01

Last updated by the study team

2022-07-07

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age >21
• No toxin treatment in last 3 months
• No filler treatment in last 3 months
• Glogau facing aging scale >=1

You may not qualify if…

• Pregnancy
• Breastfeeding
• Allergy to prior Radiesse, Belotero, Xeomin products
• History of any facial nerve palsy (ie. Bell's Palsy)

Where it is running

• Main Line Center for Laser Surgery — Ardmore, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.